| Literature DB >> 35916436 |
Joshua Teo1, Arul Suthananthan1, Ryan Pereira1, Mark Bettington2, Kellee Slater1,3.
Abstract
BACKGROUND: Groove pancreatitis (GP) is an underrecognised subtype of chronic pancreatitis, focally affecting the area between the duodenum and pancreatic head. It most commonly affects males between 40 and 50 years of age with a history of alcohol misuse. Patients most commonly complain of abdominal pain and vomiting. Due to its focal nature, it is a potentially surgically treatable form of chronic pancreatitis. We report results of patients surgically treated for groove pancreatitis followed by a literature review of patient outcomes post resection.Entities:
Keywords: groove; pancreaticoduodenectomy; pancreatitis; paraduodenal; whipples
Mesh:
Year: 2022 PMID: 35916436 PMCID: PMC9543432 DOI: 10.1111/ans.17939
Source DB: PubMed Journal: ANZ J Surg ISSN: 1445-1433 Impact factor: 2.025
PRISMA table illustrating method of literature review
|
|
Demographics of 8 patients with groove pancreatitis
| Mean age | 58.5 years |
| Gender M:F | 6:2 |
| History alcohol abuse | 5 (62.5%) |
| Current smoker | 5 (62.5%) |
| Diabetic on presentation | 5 (62.5%) |
| History of recurrent/chronic pancreatitis | 7 (87.5%) |
| Presenting complaint | |
| Gastric outlet obstruction | 7(88%) |
| Epigastric pain | 4 (50%) |
| Weight loss | 4(50%) |
| Jaundice | 2 (25%) |
Fig. 2Thickening of the second and third part of the duodenum (arrows) associated with gastric outlet obstruction.
Fig. 1Marked fibrocystic change in the groove between the pancreas and the duodenum associated with acute inflammation and abscess formation. There is florid Brunner gland hyperplasia and duodenitis. Courtesy of envoi pathology.
Fig. 3Axial CT image of groove pancreatitis with paraduodenal cysts and chronic calcific changes in the pancreatic head.
Systematic review ‐ outcome following pancreaticoduodenectomy for groove pancreatitis
| Author | Patients ( | Complete resolution pain | Partial improvement pain | Persistent severe pain | Weight gain | Follow up (months) | Peri‐Operative mortality |
|---|---|---|---|---|---|---|---|
| Chatelain (2005) | 2 | 2 | 0 | 0 | N/A | 12 | 0 |
| Jouannaud (2006) | 12 | 12 | 0 | 0 | N/A | 12 | 0 |
| Pessaux (2006) | 12 | 10 | 0 | 1 | 64 (mean) | 1 | |
| Rahman (2007) | 10 | 9 | 1 | 0 | Unspecified increase in all | 12 (median) | 0 |
| Galloro (2008) | 1 | 1 | 0 | 0 | N/A | 14 | 0 |
| Casetti (2009) | 46 | 35 | 11 | 0 | BMI increase by 2.7 | 96.3 (median) | 0 |
| Isaacs (2010) | 2 | 2 | 0 | 0 | Unspecified increase in all | 96 (mean) | 0 |
| Manzelli (2011) | 5 | ‐ | 5 | 0 | Unspecified increase in all | 12 | 0 |
| Kim (2011) | 5 | 3 | 0 | 0 | N/A | 32 | 2 |
| Goransky (2013) | 1 | 1 | 0 | 0 | N/A | 15 | 0 |
| Latham (2013) | 2 | 2 | 0 | 0 | N/A | 6 | 0 |
| Rabi (2014) | 14 | 12 | 0 | 0 | N/A | 14.2 (median) | 2 |
| Egorov (2014) | 29 | 23 | 6 | 0 | 6 kg (mean) | 19 | 0 |
| Oza (2015) | 8 | 5 | 2 | 0 | Unspecified increase in 6 | 11.52 (mean) | 1 |
| Desai (2016) | 1 | 1 | 0 | 0 | N/A | 60 | 0 |
| Sanchez‐Bueno (2016) | 8 | 7 | 0 | 1 | N/A | >12 | 0 |
| Lekkerkerker (2016) | 8 | 4 | 3 | 0 | N/A | 24 (median) | 1 |
| Total | 166 | 129 (77.7%) | 28 (16.9%) | 2 (1.2%) | – | – | 7 (4.2%) |